Page last updated: 2024-12-07

benzo(a)pyrene-7,8,9,10-tetrol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Benzo(a)pyrene-7,8,9,10-tetrol (BaP-tetrol) is a major metabolite of the potent carcinogen benzo(a)pyrene (BaP), a polycyclic aromatic hydrocarbon (PAH) found in environmental pollutants such as cigarette smoke and coal tar. BaP-tetrol is formed in the liver by cytochrome P450 enzymes and is further metabolized by detoxification enzymes. BaP-tetrol is a reactive electrophile that can bind to DNA and other cellular macromolecules, leading to DNA damage and mutations. It has been implicated in the development of cancer, particularly lung cancer. BaP-tetrol is also a potent inducer of oxidative stress, which can contribute to cell death and inflammation. The study of BaP-tetrol is important for understanding the mechanisms of carcinogenesis and for developing strategies to prevent and treat cancer. Its role as a biomarker for exposure to PAHs has been explored, with its presence in biological samples indicating exposure to BaP and potentially other PAHs.'

benzo(a)pyrene-7,8,9,10-tetrol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID115324
MeSH IDM0202248

Synonyms (5)

Synonym
bp-7,8,9,10-tetrol
benzo[a]pyrene-7,8,9,10-tetrol
73891-82-4
benzo(a)pyrene-7,8,9,10-tetrol
DTXSID50224471
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (77.78)18.2507
2000's2 (22.22)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.90 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]